SCIENCE NEWS Scientists Identify Molecular Gatekeeper of Arthritis Elimination of a molecular gatekeeper leads to the development of arthritis in mice, scientists report. [Press release from the University of Rochester Medical Center discussing online prepublication in The Journal of Experimental Medicine] Microfluidic Device Allows Collection, Analysis of Hard-to-Handle Immune Cells Researchers have developed a new microfluidic tool for quickly and accurately isolating neutrophils from small blood samples, an accomplishment that could provide information essential to better understanding the immune system’s response to traumatic injury. [Press release from Massachusetts General Hospital discussing online prepublication in Nature Medicine] Investigating Better Endpoints for Immunotherapy Trials Cancer immunotherapy calls for revised clinical endpoints that differ from those used for chemotherapy, according to an article. [Press release from EurekAlert! discussing online prepublication in The Journal of the National Cancer Institute]
|
|
INDUSTRY NEWS STEMSOFT® Software Inc. Licenses StemLab® Software to Arizona’s Celebration Stem Cell Centre STEMSOFT Software Inc., the leading provider of software solutions for the cell therapy and transplant community, is pleased to announce the licensing of StemLab, the leading cell therapy and cord blood banking laboratory software, to the Celebration Stem Cell Centre in Gilbert, Arizona. [STEMSOFT Software Inc. Press Release] Stellar Biotechnologies Files Key Patent for Company Stellar Biotechnologies, Inc. announces filing for patent protection of inventions related to its native Immunogenic (IMG) KLH technology platform and immune status monitoring product portfolio. [Stellar Biotechnologies, Inc. Press Release] ImmunoCellular Therapeutics Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced long-term data from a Phase I clinical trial of ICT-107, the Company’s lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. [ImmunoCellular Therapeutics, Ltd. Press Release]
|
|
POLICY NEWS Notice of Meeting: Secretary’s Advisory Committee on Genetics, Health, and Society (FR Doc. 2010-21532) [Department of Health and Human Services, United States] Findings of Research Misconduct (NOT-OD-10-132) [Department of Health and Human Services, United States] Protein Structure Initiative:Biology-Materials Repository (PSI:Biology-MR) (U01) (RFA-GM-11-008) [National Institute of General Medical Sciences, United States] Developing and Improving Institutional Animal Resources (G20) (RFA-RR-10-011) [National Center for Research Resources, United States] Clarification on the Roles of NIH Scientific Review Groups (SRG) and Institutional Animal Care and Use Committees (IACUC) in Review of Vertebrate Animal Research (NOT-OD-10-128) [National Institutes of Health, United States] Clarification of Eligible Institutions for PA-10-050: Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) [National Institutes of Health, United States] Center for Scientific Review; Amended Notice of Meeting (FR Doc. 2010-21816) [National Institutes of Health, United States]
|
|
EVENTS (Listed by Date) Select Biosciences 7th Annual RNAi & miRNA Europe September 14-15, 2010 Dublin, Ireland Immunology & Microbiology, Genetics & Genomics, Development, Other September 18-22, 2010 Barcelona, Spain Cell Symposia: Inflammation and Disease September 26-28, 2010 Lisbon, Portugal 11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology – DC2010: Forum on Vaccine Science September 26-30, 2010 Lugano, Switzerland 5th International Conference on Gene Regulation in Lymphocyte Development October 9-14, 2010 Chania, Greece Autumn Immunology Conference 2010 November 19-22, 2010 Chicago, United States Cell Symposia: Influenza – Translating Basic Insights December 2-4, 2010 Washington, D.C., United States
New! Phacilitate’s 7th Annual Cell & Gene Therapy Forum January 24-26, 2011 Washington DC, United States New! Keystone Symposia: Dendritic Cells and the Initiation of Adaptive Immunity joint with Cancer Control by Tumor Suppressors and Immune Effectors February 12-17, 2011 Santa Fe, United States New! Keystone Symposia: Genetics, Immunology and Repair in Multiple Sclerosis February 15-20, 2011 Taos, United States New! The 6th International Conference on Oncolytic Viruses As Cancer Therapeutics March 16-19, 2011 Las Vegas, United States New! American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting May 18-22, 2011 Seattle, United States New! Gordon Research Conferences: Viruses & Cells May 29-June 3, 2011 Lucca, Italy Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Cell Therapy Technologist (Opexa Therapeutics) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
| |
|